MAPK3 and colorectal carcinoma: First, we addressed the effect of TPL2 loss on ERK1/2 activation in CRC cell lines subjected to siRNA silencing (against IKKɛ or TPL2) and LPS stimulation (Figure 2A-B(Fig. 2)).